|
|
Cost of HIV/AIDS drugs reduced in the Central African Republic
11 September 2002. Republished courtesy of IRIN PlusNews.
|
The cost of HIV/AIDS drugs in the Central African Republic (CAR) has been reduced from 600,000 CFA francs (US $1,000) to 22,815 CFA francs (US $37) for some patients, following negotiations with foreign pharmaceutical laboratories.
The move, facilitated by UNAIDS, came during an HIV/AIDS triple therapy programme, officially inaugurated on 4 September 2002 by Health Minister Joseph Kalite. However, a quantity of medication sufficient for only 100 people will be made available during the first year, in accordance with an agreement reached with pharmaceutical companies.
"We signed an accord with Merck Sharp and Domes [USA] in July 2001, with Smith Kline [UK] and CIPLA (India) in October 2001," Dr Jean Bertrand Wata, Director of the Tripletherapy Centre and national coordinator of HIV/AIDS drugs access programme, told IRIN.
He added that during the first year, the Tripletherapy Centre would take care of 100 patients who would be chosen on the basis of very strict biological and clinical criteria, as determined by specialised medical doctors.
According to a ministerial decree, only 11 doctors in CAR are currently authorised to prescribe HIV/AIDS drugs, because of the specific training required. Wata said the training programme for HIV/AIDS drugs administration would be extended to doctors in rural areas very soon.
Acknowledging that the cost of the treatment was still well out of reach of the average CAR citizen, Wata told IRIN his centre would seek funding from the government in an effort to further reduce the cost.
CAR is the most severely HIV/AIDS-affected nation in the central African subregion and the 10th most affected in the world, with 12 percent of its population HIV-positive.
[This item is delivered to the English Service of the United Nations' IRIN humanitarian information unit, but may not necessarily reflect the views of the United Nations] |
Was this article helpful to you? |
?0%?????0%
|
|
Back
|
|
|
|